Journal article · 2023 · Open access

Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study

Se Rim Choi, Anna Shin, You‐Jung Ha, Yun Jong Lee, Eun Bong Lee, Eun Ha Kang

Arthritis Research & Therapy, 25(1), 129 · Published 26 July 2023 · DOI 10.1186/s13075-023-03111-w

Open PDFView at the publisherCite this paper

In brief

“Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study” is a 2023 journal article by Se Rim Choi and 5 co-authors, published in Arthritis Research & Therapy. OpenAlex counts 35 citations as of 19 November 2026. It is open access under a CC BY licence: the full text is free to read at Arthritis Research & Therapy.

Citations
35
Most cited in
2025 (16)
Field-weighted impact
5.68
References
31
Authors
6

Abstract

BACKGROUND: To compare infectious risk between JAK inhibitors (JAKis) versus TNF inhibitors (TNFis) among rheumatoid arthritis (RA) patients in Korea. METHODS: Using 2009-2019 Korea National Health Insurance Service database, we conducted a cohort study on RA patients initiating a JAKi or TNFi. The primary outcomes were herpes zoster (HZ), serious bacterial (SBI), and opportunistic infections (OI). Propensity-score fine-stratification (PSS) and weighting were applied to adjust for > 70 baseline covariates. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using Cox proportional hazard models comparing JAKi versus TNFi users. RESULTS: We included 2963 JAKi initiators PSS-weighted on 5169 TNFi initiators. During a follow-up of 1.16 years, the most frequent type of infections was HZ with incidence rate (IR) per 100 person-years of 11.54 and 4.88 in JAKi and TNFi users, respectively. The IR of SBI was 1.39 and 1.32, respectively. The OI was rare with a majority being tuberculosis and showed an IR of 0.11 and 0.49 in JAKi and TNFi users, respectively. The PSS-weighted HR (95% CI) for individual types of infections was 2.37 (2.00-2.80) for HZ, 1.04 (0.71-1.52) for SBI, and 0.25 (0.09-0.73) for OI. CONCLUSIONS: This population-based cohort study on RA patients treated with JAKi or TNFi in Korea showed an exceptionally high IR of HZ in both treatment groups compared to that from Western countries, with an approximately doubled risk associated with JAKi versus TNFi use. The risk of SBI was comparable, but the risk of OI, particularly tuberculosis, was less among JAKi than TNFi initiators.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Choi, S. R., Shin, A., Ha, Y., Lee, Y. J., Lee, E. B., & Kang, E. H. (2023). Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study. Arthritis Research & Therapy, 25(1), 129. https://doi.org/10.1186/s13075-023-03111-w

MLA 9

Choi, Se Rim, et al. “Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study.” Arthritis Research & Therapy, vol. 25, no. 1, 2023, p. 129. https://doi.org/10.1186/s13075-023-03111-w.

Chicago

Choi, Se Rim, Anna Shin, You‐Jung Ha, Yun Jong Lee, Eun Bong Lee, and Eun Ha Kang. 2023. “Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study.” Arthritis Research & Therapy 25 (1): 129. https://doi.org/10.1186/s13075-023-03111-w.

Harvard

Choi, S. R. et al. (2023) ‘Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study’, Arthritis Research & Therapy, 25(1), p. 129. doi:10.1186/s13075-023-03111-w.

IEEE

S. R. Choi, A. Shin, Y. Ha, Y. J. Lee, E. B. Lee, and E. H. Kang, “Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study,” Arthritis Research & Therapy, vol. 25, no. 1, p. 129, 2023, doi: 10.1186/s13075-023-03111-w.

BibTeX

@article{choi2023comparative,
  title     = {{Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study}},
  author    = {Choi, Se Rim and Shin, Anna and Ha, You‐Jung and Lee, Yun Jong and Lee, Eun Bong and Kang, Eun Ha},
  journal   = {Arthritis Research \& Therapy},
  year      = {2023},
  volume    = {25},
  number    = {1},
  pages     = {129},
  doi       = {10.1186/s13075-023-03111-w},
  url       = {https://doi.org/10.1186/s13075-023-03111-w}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202488
20251616
20261010

Its field-weighted citation impact is 5.68: it has been cited 5.68 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies

  • rheumatoid arthritis
  • JAK inhibitors
  • TNF-alpha inhibitors
  • infection risk
  • herpes zoster
  • serious bacterial infection
  • opportunistic infections
  • tuberculosis

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Choi, S. R., Shin, A., Ha, Y., Lee, Y. J., Lee, E. B., & Kang, E. H. (2023). Comparative risk of infections between JAK inhibitors versus TNF inhibitors among patients with rheumatoid arthritis: a cohort study. Arthritis Research & Therapy, 25(1), 129. https://doi.org/10.1186/s13075-023-03111-w

How many times has this paper been cited?

35 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Arthritis Research & Therapy: sign in and open the PDF from this page.

Who wrote this paper?

Se Rim Choi, Anna Shin, You‐Jung Ha, Yun Jong Lee, Eun Bong Lee, Eun Ha Kang.

What is the DOI of this paper?

10.1186/s13075-023-03111-w, permanently at https://doi.org/10.1186/s13075-023-03111-w. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.